GlassScriptPhysician profile
Marten Basta
NPI 1194103648
$4,211.92
in general payments reported to CMS, 2019-2025
7 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $350 · 2021: $439 · 2022: $162 · 2023: $347 · 2024: $2,456 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,400 · Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,400.00 |
| Food and Beverage | $520.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $2,400.00 | 2024 | |
| Medical Device Business Services, INC. | $789.95 | 2019-2021 | |
| Tela Bio, INC. | $420.44 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Stryker Corporation | $246.82 | 2021 | |
| Integra Lifesciences Corporation | $181.68 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $126.59 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Avita Medical Americas, LLC | $46.44 | 2025 | Permeaderm, Recell, Cohealyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marten Basta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.